PCN95 POLICY-MAKING FOR EXPENSIVE INNOVATIVE DRUGS IN FRANCE- ECONOMIC IMPACT AND INFLUENCE ON STAKEHOLDERS! BEHAVIOURS OF POTENTIAL DECISIONS ABOUT TAXANES
Nov 1, 2008, 00:00 AM
10.1016/S1098-3015(10)66632-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)66632-6/fulltext
Section Title :
Section Order :
467
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66632-6&doi=10.1016/S1098-3015(10)66632-6